Clinical trial stage: PT-141 has completed Phase III with long-term extension data
In highly specialised settings, a clinician might theoretically consider combining a GH-axis modulator with an incretin-based therapy for a patient with a specific, well-characterised metabolic phenotype for instance, significant visceral adiposity in the context of HIV-associated lipodystrophy who has not responded adequately to standard treatments
This could lead to better hormone balance and metabolism in PCOS patients (32)
doi: 10.1080/08982104.2020.1820521, 32
It mimics the action of two hormones, GLP-1 and GIP, that help regulate insulin production, sugar levels, and appetite
Coffee diterpenes prevent the genotoxic effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and N-nitrosodimethylamine in a human derived liver cell line (HepG2)